Filed: 8/14/2025ACC: 0001012975-25-000444
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $299.11M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$299.11M
Total AUM (reported)
49.59M
Total Shares
Allocation by class
COM$282.61M94.5%
COM NEW$16.50M5.5%
Portfolio Concentration
Top 3$192.92M64.5%
4–10$105.97M35.4%
11–25$215.6K0.1%
Top 3 weight
64.5%
Top 10 weight
99.9%
Voting Authority Distribution
Total shares with voting rights: 49.59M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
49.59M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings11
Rows:
BEAM THERAPEUTICS INC.
SOLEShares4.54M
TypeSH
Market value$77.23M
25.82%
Sole
0.00
Shared
0.00
None
4.54M
VIR BIOTECHNOLOGY INC.
SOLEShares12.92M
TypeSH
Market value$65.10M
21.76%
Sole
0.00
Shared
0.00
None
12.92M
MAZE THERAPEUTICS INC.
SOLEShares4.12M
TypeSH
Market value$50.59M
16.91%
Sole
0.00
Shared
0.00
None
4.12M
RAPPORT THERAPEUTICS INC.
SOLEShares3.73M
TypeSH
Market value$42.43M
14.19%
Sole
0.00
Shared
0.00
None
3.73M
VERVE THERAPEUTICS INC.
SOLEShares2.01M
TypeSH
Market value$22.56M
7.54%
Sole
0.00
Shared
0.00
None
2.01M
LYELL IMMUNOPHARMA INC.
SOLEShares1.82M
TypeSH
Market value$16.11M
5.39%
Sole
0.00
Shared
0.00
None
1.82M
ERASCA INC.
SOLEShares11.06M
TypeSH
Market value$14.10M
4.71%
Sole
0.00
Shared
0.00
None
11.06M
GOSSAMER BIO INC.
SOLEShares8.06M
TypeSH
Market value$9.91M
3.31%
Sole
0.00
Shared
0.00
None
8.06M
Q32 BIO INC.
SOLEShares320.48K
TypeSH
Market value$477.5K
0.16%
Sole
0.00
Shared
0.00
None
320.48K
UNITY BIOTECHNOLOGY INC.
SOLEShares1M
TypeSH
Market value$385.9K
0.13%
Sole
0.00
Shared
0.00
None
1M
CERO THERAPEUTICS HOLDINGS INC.
SOLEShares22.39K
TypeSH
Market value$215.6K
0.07%
Sole
0.00
Shared
0.00
None
22.39K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INC.SOLE | COM | 4.54M | SH | $77.23M 25.82% | 0.00 | 0.00 | 4.54M |
VIR BIOTECHNOLOGY INC.SOLE | COM | 12.92M | SH | $65.10M 21.76% | 0.00 | 0.00 | 12.92M |
MAZE THERAPEUTICS INC.SOLE | COM | 4.12M | SH | $50.59M 16.91% | 0.00 | 0.00 | 4.12M |
RAPPORT THERAPEUTICS INC.SOLE | COM | 3.73M | SH | $42.43M 14.19% | 0.00 | 0.00 | 3.73M |
VERVE THERAPEUTICS INC.SOLE | COM | 2.01M | SH | $22.56M 7.54% | 0.00 | 0.00 | 2.01M |
LYELL IMMUNOPHARMA INC.SOLE | COM NEW | 1.82M | SH | $16.11M 5.39% | 0.00 | 0.00 | 1.82M |
ERASCA INC.SOLE | COM | 11.06M | SH | $14.10M 4.71% | 0.00 | 0.00 | 11.06M |
GOSSAMER BIO INC.SOLE | COM | 8.06M | SH | $9.91M 3.31% | 0.00 | 0.00 | 8.06M |
Q32 BIO INC.SOLE | COM | 320.48K | SH | $477.5K 0.16% | 0.00 | 0.00 | 320.48K |
UNITY BIOTECHNOLOGY INC.SOLE | COM NEW | 1M | SH | $385.9K 0.13% | 0.00 | 0.00 | 1M |
CERO THERAPEUTICS HOLDINGS INC.SOLE | COM | 22.39K | SH | $215.6K 0.07% | 0.00 | 0.00 | 22.39K |